Safety evaluation of the use of the non-genetically modified
EC 3.2.1.23
Hamamotoa singularis
Sporobolomyces singularis
food enzyme
galacto‐oligosaccharides
β‐D‐galactoside galactohydrolase
β‐Galactosidase
Journal
EFSA journal. European Food Safety Authority
ISSN: 1831-4732
Titre abrégé: EFSA J
Pays: United States
ID NLM: 101642076
Informations de publication
Date de publication:
Nov 2022
Nov 2022
Historique:
entrez:
25
11
2022
pubmed:
26
11
2022
medline:
26
11
2022
Statut:
epublish
Résumé
This assessment addresses the enzyme β-galactosidase which is not separated from the yeast cells used for its production. The β-galactosidase (β-D-galactoside galactohydrolase, EC 3.2.1.23) is produced with the non-genetically modified
Identifiants
pubmed: 36425217
doi: 10.2903/j.efsa.2022.7650
pii: EFS27650
pmc: PMC9679640
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e07650Informations de copyright
© 2022 Wiley‐VCH Verlag GmbH & Co. KgaA on behalf of the European Food Safety Authority.
Références
Allergol Immunopathol (Madr). 2009 Jul-Aug;37(4):203-4
pubmed: 19775798
Arch Environ Occup Health. 2016 Sep 2;71(5):259-267
pubmed: 26134755
EFSA J. 2021 Oct 21;19(10):e06851
pubmed: 34721697
J Biosci Bioeng. 2005 Apr;99(4):331-9
pubmed: 16233798
Allergy Asthma Clin Immunol. 2016 Dec 13;12:66
pubmed: 27999602
EFSA J. 2019 Jun 11;17(6):e05741
pubmed: 32626359
Occup Environ Med. 2002 Jul;59(7):498-502; quiz 502, 426
pubmed: 12107305
Mol Nutr Food Res. 2004 Nov;48(6):413-23
pubmed: 15508176
EFSA J. 2021 Dec 20;19(12):e07010
pubmed: 34976163
Allergy. 1997 Mar;52(3):346-9
pubmed: 9140529